×
About 2,903 results

ALLMedicine™ Patent Foramen Ovale Center

Research & Reviews  1,025 results

Atrial Septal Aneurysms - A Clinically Relevant Enigma?
https://doi.org/10.1016/j.hlc.2021.07.025
Heart, Lung & Circulation; Cho K, Feneley M et. al.

Sep 12th, 2021 - Atrial septal aneurysms (ASAs) are often seen during routine cardiac imaging, though their clinical relevance has been poorly defined. The aneurysmal, and often mobile, inter-atrial septum is frequently associated with other clinically relevant st...

Patent Foramen Ovale Closure Decreases the Incidence but Not the Size of New Brain Infa...
https://doi.org/10.1161/STROKEAHA.121.034451
Stroke Messé SR, Erus G et. al.

Aug 31st, 2021 - Randomized patent foramen ovale closure trials have used open-label end point ascertainment which increases the risk of bias and undermines confidence in the conclusions. The Gore REDUCE trial prospectively performed baseline and follow-up magneti...

Prevention of Patent Foramen Ovale-Related Stroke: An Evolving Concept.
https://doi.org/10.1161/STROKEAHA.121.035735
Stroke Di Tullio MR

Aug 31st, 2021 - Prevention of Patent Foramen Ovale-Related Stroke: An Evolving Concept.|2021|Di Tullio MR,|

A 59-Year-Old Woman with Familial Brugada Syndrome and the c.664C>T Variant of the Sodi...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409454
The American Journal of Case Reports; Katsaras D, Sanjeev Kumar BT et. al.

Aug 28th, 2021 - BACKGROUND Brugada syndrome is a rare inherited channelopathy that can lead to sudden cardiac death. The discovery of new variants of variable penetrance along with the current guidance for cascade family screening can be expected to lead to an in...

see more →

Guidelines  5 results

SCAI expert consensus statement on operator and institutional requirements for PFO clos...
https://doi.org/10.1002/ccd.28111
Catheterization and Cardiovascular Interventions : Offici... Horlick E, Kavinsky CJ et. al.

Mar 22nd, 2019 - Until recently, evidence to support Patent Foramen Ovale (PFO) closure for secondary prevention of recurrent stroke has been controversial. Publication of high-quality evidence from randomized clinical trials and the subsequent FDA approval of two...

Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058599
BMJ (Clinical Research Ed.); Kuijpers T, Spencer FA et. al.

Jul 27th, 2018 - Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline.|2018|Kuijpers T,Spencer FA,Siemieniuk RAC,Vandvik PO,Otto CM,|therapeutic use,methods,surgery,...

Guidelines for the primary prevention of stroke: a statement for healthcare professiona...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020564
Stroke Meschia JF, Bushnell C et. al.

Oct 31st, 2014 - The aim of this updated statement is to provide comprehensive and timely evidence-based recommendations on the prevention of stroke among individuals who have not previously experienced a stroke or transient ischemic attack. Evidence-based recomme...

Management of patients with patent foramen ovale and cryptogenic stroke: a collaborativ...
https://doi.org/10.1002/ccd.24693
Catheterization and Cardiovascular Interventions : Offici... Pristipino C, Anzola GP et. al.

Jun 22nd, 2013 - To organize a common approach on the management of patent foramen ovale (PFO) and cryptogenic stroke that may be shared by different specialists. The management of PFO related to cryptogenic stroke is controversial, despite an increase in interven...

Valvular and structural heart disease: American College of Chest Physicians Evidence-Ba...
https://doi.org/10.1378/chest.08-0724
Chest Salem DN, O'Gara PT et. al.

Jul 24th, 2008 - This chapter about antithrombotic therapy for valvular heart disease is part of the American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Grade 1 recommendations are strong and indicate that the benefits d...

see more →

Drugs  1 results see all →

News  129 results

New AHA/ASA Guideline on Secondary Stroke Prevention
https://www.medscape.com/viewarticle/951824

May 25th, 2021 - When possible, diagnostic tests to determine the cause of a first stroke or transient ischemic attack (TIA) should be completed within 48 hours after symptom onset, the American Heart Association (AHA)/American Stroke Association (ASA) says in an ...

PFO Closure Reduces Migraine: New Meta-Analysis
https://www.medscape.com/viewarticle/945479

Feb 8th, 2021 - A meta-analysis of two randomized studies evaluating patent foramen ovale (PFO) closure as a treatment strategy for migraine has shown significant benefits in several key endpoints, prompting the authors to conclude the approach warrants re-evalua...

PFO Closure Reduces Migraine: New Meta-Analysis
https://www.medscape.com/viewarticle/945479?src=sapfe

Feb 8th, 2021 - A meta-analysis of two randomized studies evaluating patent foramen ovale (PFO) closure as a treatment strategy for migraine has shown significant benefits in several key endpoints, prompting the authors to conclude the approach warrants re-evalua...

PFO Closure Beneficial in Stroke Patients With Thrombophilia
https://www.medscape.com/viewarticle/942174

Dec 7th, 2020 - Thrombophilic patients who have had an ischemic stroke and have a patent foramen ovale (PFO) benefit from having the PFO closed, a new study suggests. "To the best of our knowledge, this is the largest prospective study on recurrent events in hype...

Report Touts PFO Closure in Divers; Experts Disagree
https://www.medscape.com/viewarticle/936439

Aug 27th, 2020 - A new report recommends the surgical closure of patent foramen ovale in high-risk divers, but physicians in the United States urged caution about widespread use of the procedure in this population. "PFO closure is recommended in divers with a high...

see more →

Patient Education  1 results see all →